Tempus to Report Second Quarter 2026 Financial Results on July 30

Tempus AI (NASDAQ: TEM) will report Q2 2026 results for the quarter ended June 30, 2026 on Thursday, July 30, 2026, followed by a conference call and webcast at 4:30 p.m. ET. Management, led by CEO Eric Lefkofsky and CFO Jim Rogers, will discuss the results and provide a business update.

Analysis

This is not a fundamentals event by itself; it is a positioning event. For a high-duration healthcare software/diagnostics name like TEM, the market usually trades the print on whether management proves operating leverage and cash discipline, not on the existence of an earnings date. That means the real risk is a “good enough” update that still disappoints a crowded growth holder base and compresses the multiple even if the top line looks fine.

The second-order read-through is to adjacent precision-medicine names such as GH, EXAS, and ILMN: any evidence that TEM is converting AI narrative into repeatable workflow adoption would support the entire basket, while a weak update would pressure the group through sentiment rather than fundamentals. The more important mechanism is customer bargaining power — if growth is decelerating, large health-system clients and channel partners can push for better pricing, which hits gross margin before it shows up in revenue.

The only meaningful catalyst over the next 1-3 months is the call itself plus any change in full-year guide, gross margin, and free-cash-flow trajectory. A durable bull case requires proof that AI-driven commercialization is lowering CAC or lifting retention; otherwise the stock remains a story multiple with earnings-date volatility. The contrarian view is that expectations may already embed a lot of execution, so the asymmetry may actually favor waiting for the print rather than buying the narrative ahead of it.

Key Decisions for Investors

• No pre-earnings directional trade in TEM; treat this as a calendar event, not an information edge. Reassess only after the call if management changes FY guide or cash-burn trajectory.
• Set a post-print alert for a 10%+ gap move in TEM: if the stock gaps up on margin/FCF improvement, consider a 1-3 month long TEM / short GH or EXAS pair to express relative operating-leverage upside.
• If the print shows slower growth or wider burn, fade the bounce rather than chase the gap. The short thesis works best if the stock fails to reclaim the pre-earnings level within 3-5 trading sessions.
• Watch ILMN/GH/EXAS into the call for sympathy strength or weakness; use TEM as the read-through only if management gives evidence of scalable commercial traction, not just AI branding.
• If implied volatility is elevated into the print, prefer waiting over buying calls. The event is more likely to be a volatility reset than a clean directional catalyst unless guidance is raised.